| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 DCHS1 CDH15 PLXNB3 | 2.46e-07 | 187 | 97 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 8.30e-06 | 9 | 97 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHAC2 PCDHA12 PCDHA7 PCDHA5 PCDHA4 DCHS1 CDH15 PLXNB3 | 1.69e-05 | 313 | 97 | 9 | GO:0098742 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 8.74e-06 | 9 | 100 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.72e-05 | 14 | 100 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.62e-04 | 75 | 100 | 4 | GO:0035097 | |
| Domain | Cadherin_CS | 1.06e-07 | 109 | 98 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 1.40e-07 | 113 | 98 | 8 | PS00232 | |
| Domain | Cadherin | 1.40e-07 | 113 | 98 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 1.50e-07 | 114 | 98 | 8 | PS50268 | |
| Domain | - | 1.50e-07 | 114 | 98 | 8 | 2.60.40.60 | |
| Domain | CA | 1.60e-07 | 115 | 98 | 8 | SM00112 | |
| Domain | Cadherin-like | 1.71e-07 | 116 | 98 | 8 | IPR015919 | |
| Domain | Cadherin | 1.96e-07 | 118 | 98 | 8 | IPR002126 | |
| Domain | DUF2012 | 5.58e-07 | 4 | 98 | 3 | PF09430 | |
| Domain | DUF2012 | 5.58e-07 | 4 | 98 | 3 | IPR019008 | |
| Domain | Cadherin_tail | 1.37e-06 | 37 | 98 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.37e-06 | 37 | 98 | 5 | IPR031904 | |
| Domain | Carb-bd-like_fold | 7.70e-06 | 8 | 98 | 3 | IPR013784 | |
| Domain | Cadherin_2 | 2.31e-05 | 65 | 98 | 5 | PF08266 | |
| Domain | Cadherin_N | 2.31e-05 | 65 | 98 | 5 | IPR013164 | |
| Domain | CarboxyPept_regulatory_dom | 3.86e-05 | 13 | 98 | 3 | IPR014766 | |
| Domain | - | 3.86e-05 | 13 | 98 | 3 | 2.60.40.1120 | |
| Domain | Post-SET_dom | 7.47e-05 | 16 | 98 | 3 | IPR003616 | |
| Domain | PostSET | 7.47e-05 | 16 | 98 | 3 | SM00508 | |
| Domain | POST_SET | 7.47e-05 | 16 | 98 | 3 | PS50868 | |
| Domain | CarboxyPept-like_regulatory | 9.03e-05 | 17 | 98 | 3 | IPR008969 | |
| Domain | FYrich_C | 2.70e-04 | 5 | 98 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.70e-04 | 5 | 98 | 2 | IPR003888 | |
| Domain | FYRC | 2.70e-04 | 5 | 98 | 2 | SM00542 | |
| Domain | FYRN | 2.70e-04 | 5 | 98 | 2 | SM00541 | |
| Domain | FYRN | 2.70e-04 | 5 | 98 | 2 | PF05964 | |
| Domain | FYRC | 2.70e-04 | 5 | 98 | 2 | PF05965 | |
| Domain | FYRC | 2.70e-04 | 5 | 98 | 2 | PS51543 | |
| Domain | FYRN | 2.70e-04 | 5 | 98 | 2 | PS51542 | |
| Domain | IPT | 3.74e-04 | 27 | 98 | 3 | SM00429 | |
| Domain | TIG | 5.66e-04 | 31 | 98 | 3 | PF01833 | |
| Domain | IPT | 6.22e-04 | 32 | 98 | 3 | IPR002909 | |
| Domain | - | PLXNA3 INSRR OBSL1 PHYHIP NOMO1 NOMO2 PKHD1 RIMBP2 NOMO3 IL6ST PLXNB3 | 7.06e-04 | 663 | 98 | 11 | 2.60.40.10 |
| Domain | PTEN_C2 | 7.48e-04 | 8 | 98 | 2 | PF10409 | |
| Domain | PTEN_C2 | 7.48e-04 | 8 | 98 | 2 | SM01326 | |
| Domain | C2_TENSIN | 7.48e-04 | 8 | 98 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 7.48e-04 | 8 | 98 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 7.48e-04 | 8 | 98 | 2 | IPR014020 | |
| Domain | Plexin_cytopl | 9.58e-04 | 9 | 98 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 9.58e-04 | 9 | 98 | 2 | IPR013548 | |
| Domain | Plexin | 9.58e-04 | 9 | 98 | 2 | IPR031148 | |
| Domain | PPASE_TENSIN | 9.58e-04 | 9 | 98 | 2 | PS51181 | |
| Domain | Ig-like_fold | PLXNA3 INSRR OBSL1 PHYHIP NOMO1 NOMO2 PKHD1 RIMBP2 NOMO3 IL6ST PLXNB3 | 1.18e-03 | 706 | 98 | 11 | IPR013783 |
| Domain | SET | 1.29e-03 | 41 | 98 | 3 | PF00856 | |
| Domain | Kinesin_motor_CS | 1.29e-03 | 41 | 98 | 3 | IPR019821 | |
| Domain | - | 1.59e-03 | 44 | 98 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 1.59e-03 | 44 | 98 | 3 | PF00225 | |
| Domain | KISc | 1.59e-03 | 44 | 98 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.59e-03 | 44 | 98 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.59e-03 | 44 | 98 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.59e-03 | 44 | 98 | 3 | PS50067 | |
| Domain | fn3 | 1.64e-03 | 162 | 98 | 5 | PF00041 | |
| Domain | SET | 1.81e-03 | 46 | 98 | 3 | SM00317 | |
| Domain | Inhibin_asu | 2.05e-03 | 13 | 98 | 2 | IPR002405 | |
| Domain | SET_dom | 2.30e-03 | 50 | 98 | 3 | IPR001214 | |
| Domain | SET | 2.30e-03 | 50 | 98 | 3 | PS50280 | |
| Domain | FN3 | 2.92e-03 | 185 | 98 | 5 | SM00060 | |
| Domain | PKS_ER | 3.12e-03 | 16 | 98 | 2 | IPR020843 | |
| Domain | PKS_ER | 3.12e-03 | 16 | 98 | 2 | SM00829 | |
| Domain | FN3 | 3.98e-03 | 199 | 98 | 5 | PS50853 | |
| Domain | ADH_zinc_N | 4.40e-03 | 19 | 98 | 2 | PF00107 | |
| Domain | ADH_C | 4.40e-03 | 19 | 98 | 2 | IPR013149 | |
| Domain | FN3_dom | 4.90e-03 | 209 | 98 | 5 | IPR003961 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC PLXNA3 DGCR2 SPHK2 MORN1 VWA8 INPPL1 NSD1 CHD8 GRIN2D WRAP53 ANKHD1 KIFC2 DHX30 KMT2C BMP8B FASN KMT2D ZNF341 SCN8A SIPA1L2 DNMBP | 6.28e-13 | 1105 | 100 | 22 | 35748872 |
| Pubmed | 5.21e-10 | 15 | 100 | 5 | 15640798 | ||
| Pubmed | 1.07e-09 | 17 | 100 | 5 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.48e-09 | 18 | 100 | 5 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.48e-09 | 18 | 100 | 5 | 10662547 | |
| Pubmed | 7.23e-09 | 24 | 100 | 5 | 24698270 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.09e-08 | 11 | 100 | 4 | 9655502 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.31e-08 | 3 | 100 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 9.21e-08 | 4 | 100 | 3 | 31833031 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 9267806 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 6.61e-07 | 57 | 100 | 5 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 7.21e-07 | 58 | 100 | 5 | 30377227 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GAK CAD INPPL1 OBSL1 ZNF217 NOMO2 DLD ATP1A1 EIF3I SIPA1L2 DNMBP | 1.07e-06 | 588 | 100 | 11 | 38580884 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.25e-06 | 28 | 100 | 4 | 15347688 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.28e-06 | 8 | 100 | 3 | 15257293 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 1.60e-06 | 68 | 100 | 5 | 11230163 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 1.91e-06 | 31 | 100 | 4 | 19136429 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.91e-06 | 9 | 100 | 3 | 36261522 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 12154121 | ||
| Pubmed | 2.04e-06 | 202 | 100 | 7 | 24639526 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.13e-06 | 72 | 100 | 5 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.45e-06 | 74 | 100 | 5 | 10817752 | |
| Pubmed | 2.98e-06 | 77 | 100 | 5 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.60e-06 | 80 | 100 | 5 | 10716726 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 3.74e-06 | 11 | 100 | 3 | 32820719 | |
| Pubmed | 4.30e-06 | 549 | 100 | 10 | 38280479 | ||
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 4.98e-06 | 12 | 100 | 3 | 10612399 | |
| Pubmed | 5.15e-06 | 329 | 100 | 8 | 17474147 | ||
| Pubmed | 6.69e-06 | 242 | 100 | 7 | 34011540 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28483418 | ||
| Pubmed | Human BMP8A suppresses luteinization of rat granulosa cells via the SMAD1/5/8 pathway. | 8.18e-06 | 2 | 100 | 2 | 31940275 | |
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 8.18e-06 | 2 | 100 | 2 | 34156443 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9463357 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8682296 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31924266 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27280393 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 36869380 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28967912 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21277400 | ||
| Pubmed | Structure of the planar cell polarity cadherins Fat4 and Dachsous1. | 8.18e-06 | 2 | 100 | 2 | 36797229 | |
| Pubmed | Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture. | 8.18e-06 | 2 | 100 | 2 | 25930014 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25346535 | ||
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 8.18e-06 | 2 | 100 | 2 | 25355906 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 36601880 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 1.43e-05 | 272 | 100 | 7 | 25315684 | |
| Pubmed | Functional analysis of candidate genes from genome-wide association studies of hearing. | 1.52e-05 | 17 | 100 | 3 | 31927188 | |
| Pubmed | 1.93e-05 | 653 | 100 | 10 | 22586326 | ||
| Pubmed | 2.39e-05 | 407 | 100 | 8 | 12693553 | ||
| Pubmed | 2.45e-05 | 534 | 100 | 9 | 35032548 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 9076678 | ||
| Pubmed | Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). | 2.45e-05 | 3 | 100 | 2 | 12925636 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23932714 | ||
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 2.45e-05 | 3 | 100 | 2 | 22183980 | |
| Pubmed | Requirement of Bmp8b for the generation of primordial germ cells in the mouse. | 2.45e-05 | 3 | 100 | 2 | 10894154 | |
| Pubmed | BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. | 2.45e-05 | 3 | 100 | 2 | 22579288 | |
| Pubmed | Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. | 2.45e-05 | 3 | 100 | 2 | 11784057 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 21683083 | ||
| Pubmed | In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme. | 2.45e-05 | 3 | 100 | 2 | 20082125 | |
| Pubmed | Estrogen mediated epithelial proliferation in the uterus is directed by stromal Fgf10 and Bmp8a. | 2.45e-05 | 3 | 100 | 2 | 25451979 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 2.50e-05 | 119 | 100 | 5 | 28625976 | |
| Pubmed | 3.27e-05 | 209 | 100 | 6 | 36779422 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 4.24e-05 | 219 | 100 | 6 | 31353912 | |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 4.89e-05 | 4 | 100 | 2 | 19221051 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 34645806 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 28398509 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 18765673 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 9434160 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 8843393 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 4.89e-05 | 4 | 100 | 2 | 23129768 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 24081332 | ||
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 5.07e-05 | 25 | 100 | 3 | 9275178 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 6.69e-05 | 75 | 100 | 4 | 15372022 | |
| Pubmed | Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF. | 8.14e-05 | 5 | 100 | 2 | 31127101 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 24056717 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 27835672 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 9383296 | ||
| Pubmed | MLL3/MLL4-Associated PAGR1 Regulates Adipogenesis by Controlling Induction of C/EBPβ and C/EBPδ. | 8.14e-05 | 5 | 100 | 2 | 32601106 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 26744420 | ||
| Pubmed | The genomic organization of a human creatine transporter (CRTR) gene located in Xq28. | 8.14e-05 | 5 | 100 | 2 | 8661155 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 34888534 | ||
| Pubmed | CAD NSD1 CHD8 ZNF217 WRAP53 ANKHD1 DHX30 NOMO1 SLC25A3 MED24 KMT2C PWP2 EIF3I DNMBP | 9.76e-05 | 1497 | 100 | 14 | 31527615 | |
| Pubmed | 1.18e-04 | 33 | 100 | 3 | 30783098 | ||
| Pubmed | A Functional Link between AMPK and Orexin Mediates the Effect of BMP8B on Energy Balance. | 1.22e-04 | 6 | 100 | 2 | 27524625 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 9878243 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 7605753 | ||
| Pubmed | CHARGE and Kabuki syndromes: a phenotypic and molecular link. | 1.22e-04 | 6 | 100 | 2 | 24705355 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 19506035 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 1.22e-04 | 6 | 100 | 2 | 17021013 | |
| Pubmed | 1.45e-04 | 832 | 100 | 10 | 36724073 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 30604749 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 36598580 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 16059920 | ||
| Pubmed | Dchs1-Fat4 regulation of polarized cell behaviours during skeletal morphogenesis. | 1.70e-04 | 7 | 100 | 2 | 27145737 | |
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 9070944 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 19556342 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 12107726 | ||
| Pubmed | 2.07e-04 | 186 | 100 | 5 | 14744259 | ||
| Pubmed | 2.27e-04 | 8 | 100 | 2 | 15661641 | ||
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 2.27e-04 | 8 | 100 | 2 | 21447625 | |
| Interaction | TOP3B interactions | ZXDC PLXNA3 DGCR2 SPHK2 CAD MORN1 VWA8 INPPL1 NSD1 CHD8 GRIN2D WRAP53 ANKHD1 KIFC2 DHX30 KMT2C BMP8B FASN KMT2D ZNF341 SCN8A SIPA1L2 DNMBP | 5.18e-07 | 1470 | 99 | 23 | int:TOP3B |
| Interaction | PCDHA10 interactions | 3.74e-06 | 22 | 99 | 4 | int:PCDHA10 | |
| Cytoband | 5q31 | 5.63e-06 | 115 | 100 | 5 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 5.08e-05 | 298 | 100 | 6 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.89e-04 | 129 | 100 | 4 | chr2q35 | |
| Cytoband | Xq28 | 6.15e-04 | 176 | 100 | 4 | Xq28 | |
| Cytoband | 4p16 | 6.25e-04 | 17 | 100 | 2 | 4p16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 1.25e-03 | 213 | 100 | 4 | chrXq28 | |
| Cytoband | 11q13 | 2.23e-03 | 118 | 100 | 3 | 11q13 | |
| Cytoband | 1p35.1 | 2.23e-03 | 32 | 100 | 2 | 1p35.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 3.40e-03 | 137 | 100 | 3 | chr1p35 | |
| GeneFamily | Clustered protocadherins | 5.92e-06 | 64 | 73 | 5 | 20 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.45e-04 | 34 | 73 | 3 | 487 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.43e-04 | 8 | 73 | 2 | 837 | |
| GeneFamily | Plexins | 5.68e-04 | 9 | 73 | 2 | 683 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 8.46e-04 | 46 | 73 | 3 | 622 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 8.64e-04 | 11 | 73 | 2 | 455 | |
| GeneFamily | Cadherin related | 2.10e-03 | 17 | 73 | 2 | 24 | |
| GeneFamily | PDZ domain containing | 3.33e-03 | 152 | 73 | 4 | 1220 | |
| GeneFamily | PHD finger proteins | 5.77e-03 | 90 | 73 | 3 | 88 | |
| Coexpression | PEREZ_TP53_TARGETS | PLIN4 ZXDC ANKRD65 GAK TP53I3 USH1C CEP43 F8 KIF9 ZNF341 AUTS2 RIMBP2 MTCL1 SIPA1L2 TNS1 CCS | 9.37e-06 | 1201 | 98 | 16 | M4391 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-07 | 185 | 100 | 7 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-06 | 170 | 100 | 6 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-06 | 181 | 100 | 6 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-06 | 182 | 100 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-06 | 183 | 100 | 6 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 185 | 100 | 6 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 185 | 100 | 6 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 185 | 100 | 6 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 185 | 100 | 6 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 185 | 100 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-06 | 187 | 100 | 6 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-06 | 191 | 100 | 6 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.63e-06 | 191 | 100 | 6 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-06 | 192 | 100 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.77e-06 | 192 | 100 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-05 | 164 | 100 | 5 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.87e-05 | 168 | 100 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.87e-05 | 168 | 100 | 5 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 4.96e-05 | 177 | 100 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-05 | 179 | 100 | 5 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.37e-05 | 180 | 100 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-05 | 180 | 100 | 5 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 181 | 100 | 5 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-05 | 182 | 100 | 5 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-05 | 182 | 100 | 5 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-05 | 182 | 100 | 5 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 6.11e-05 | 185 | 100 | 5 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.11e-05 | 185 | 100 | 5 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 246503fd4e6ae24041c606b069eb5fb313e60f73 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | ef93ac469eb4f63db036f14b442c1503b8c6de38 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 6.27e-05 | 186 | 100 | 5 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 188 | 100 | 5 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 188 | 100 | 5 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 188 | 100 | 5 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 188 | 100 | 5 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 188 | 100 | 5 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.76e-05 | 189 | 100 | 5 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 6.76e-05 | 189 | 100 | 5 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.11e-05 | 191 | 100 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 192 | 100 | 5 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 192 | 100 | 5 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 643a360d3358bad52f0737c0d55195b69007c29b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 195 | 100 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 100 | 5 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.22e-05 | 197 | 100 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-05 | 198 | 100 | 5 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 199 | 100 | 5 | 6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 8.62e-05 | 199 | 100 | 5 | 7b21447bb39cdba37539a12cb475f463010fc23f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.83e-05 | 200 | 100 | 5 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.83e-05 | 200 | 100 | 5 | 0ff2607c58bc929e203f407ecf3605e0b21bfa90 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.83e-05 | 200 | 100 | 5 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.83e-05 | 200 | 100 | 5 | de23a5d22d94935802b5b84a9e029b3f62c57028 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.83e-05 | 200 | 100 | 5 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.83e-05 | 200 | 100 | 5 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.43e-06 | 26 | 95 | 4 | DOID:9351 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 2.25e-06 | 29 | 95 | 4 | EFO_0008009 | |
| Disease | visceral adipose tissue measurement, body mass index | 9.33e-06 | 87 | 95 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 1.03e-05 | 2 | 95 | 2 | C1832390 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Van Maldergem syndrome | 1.03e-05 | 2 | 95 | 2 | cv:C1832390 | |
| Disease | Periventricular gray matter heterotopia | 1.03e-05 | 2 | 95 | 2 | C1849173 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 3.07e-05 | 3 | 95 | 2 | C1842563 | |
| Disease | obesity (implicated_via_orthology) | 7.07e-05 | 215 | 95 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.00e-04 | 447 | 95 | 8 | C3714756 | |
| Disease | Choledochal Cyst, Type I | 1.02e-04 | 5 | 95 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 1.02e-04 | 5 | 95 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 1.02e-04 | 5 | 95 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 1.02e-04 | 5 | 95 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 1.02e-04 | 5 | 95 | 2 | C1257799 | |
| Disease | Choledochal Cyst | 1.02e-04 | 5 | 95 | 2 | C0008340 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.26e-04 | 239 | 95 | 6 | EFO_0010934 | |
| Disease | Squamous cell carcinoma of esophagus | 2.57e-04 | 95 | 95 | 4 | C0279626 | |
| Disease | Adenoid Cystic Carcinoma | 3.12e-04 | 100 | 95 | 4 | C0010606 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 3.64e-04 | 9 | 95 | 2 | C0085548 | |
| Disease | post-traumatic stress disorder | 5.03e-04 | 202 | 95 | 5 | EFO_0001358 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 5.54e-04 | 11 | 95 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 7.82e-04 | 13 | 95 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | tea consumption measurement | 8.16e-04 | 129 | 95 | 4 | EFO_0010091 | |
| Disease | Profound Mental Retardation | 1.08e-03 | 139 | 95 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.08e-03 | 139 | 95 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.08e-03 | 139 | 95 | 4 | C0917816 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.45e-03 | 69 | 95 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | vital capacity | PDE3A PDGFB PCDHA12 PCDHA7 PCDHA5 PCDHA4 ZNF341 AUTS2 MTCL1 ASIC4 TNS1 | 2.08e-03 | 1236 | 95 | 11 | EFO_0004312 |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.22e-03 | 80 | 95 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | 2.38e-03 | 566 | 95 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.38e-03 | 82 | 95 | 3 | EFO_0008535 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 2.91e-03 | 88 | 95 | 3 | EFO_0000341, EFO_0006527 | |
| Disease | glycerol measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0010115 | |
| Disease | triacylglycerol 48:0 measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0010403 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGSLDLALEGGVDSP | 461 | Q9Y6N9 | |
| VTGGILGPGNHLLDS | 2186 | Q9HCK8 | |
| LEIHDGGDVTAPRLG | 1856 | Q96PZ7 | |
| VFDLLILGVGPDGHT | 141 | O95336 | |
| LGAEPLEIHGTLATG | 216 | Q6PL45 | |
| ALGLPEGETHTGTAL | 366 | Q86TY3 | |
| LLTPGAGTEEIIGGH | 11 | P20718 | |
| NGTISLLGPLDVHAG | 946 | Q6V0I7 | |
| GSAPLAIGLSVALGH | 166 | P29972 | |
| VGPVFLGHRDELEGT | 851 | Q6XZF7 | |
| DLHLIEPLDEGGEGG | 136 | P78325 | |
| TDLVLHIDARGEPGG | 656 | Q7L2E3 | |
| LGGGHAELPQLTLSV | 1361 | Q96L73 | |
| LLLSGVGPAHGSEDI | 21 | P69849 | |
| LGLEASGHVAELGPG | 61 | Q53FA7 | |
| EGEHPETLSRLGELG | 1066 | Q9Y4B5 | |
| LGALHGQEDTPGGLL | 331 | Q5T089 | |
| STPGGDLELVVHLSG | 1281 | O75147 | |
| SVHLEEAGILRAGPG | 806 | Q9UN72 | |
| LGPSGGPAHELELEA | 956 | Q96JQ0 | |
| GPAHELELEARDGGS | 961 | Q96JQ0 | |
| LLLSGVGPAHGSEDI | 21 | Q5JPE7 | |
| RLAALGPEGAHGDTT | 611 | Q16849 | |
| LVHDGLGDLRSSSPG | 21 | Q00325 | |
| HEEGDGLTDGPARLL | 4406 | Q8NEZ4 | |
| TEEGDSPLGDHVGSL | 161 | P16333 | |
| GLEGGQTPIAAEIEH | 276 | P05023 | |
| VGQAGLELLTSGHPA | 6 | Q58FG0 | |
| RLLHGDPGEEDGAEL | 46 | P01127 | |
| GGLHVIEGLPLLADS | 396 | P51805 | |
| PGHVLDVEGEGLNLG | 1166 | Q9ULL4 | |
| RGLEELGHGPLSLAG | 591 | Q76G19 | |
| IGLGVGEDHLLSLPA | 176 | Q14432 | |
| LLLSGVGPAHGSEDI | 21 | Q15155 | |
| LGVGTLPEHDSQDAG | 251 | Q8WXX7 | |
| NGSPGHLDLVEGSLL | 1531 | P00451 | |
| DIEVLLGHGADPGIR | 251 | E5RJM6 | |
| IECADHTLDSLGGGP | 351 | Q96FT7 | |
| AGLVDVDGHLVGEPE | 461 | Q9HAQ2 | |
| VHLEEAGILRAGPGG | 806 | Q9Y5H7 | |
| VDSVGAAALLGLGPH | 321 | Q04756 | |
| LTESGGDLVHLEGPL | 21 | P0DTE2 | |
| SVHLEEAGILRAGPG | 876 | Q9Y5I4 | |
| SVHLEEAGILRAGPG | 816 | Q9UN74 | |
| VDLLGLHSEVGAGPA | 881 | O14976 | |
| LQLVDHVDGGDGILP | 796 | P40189 | |
| LLGGEELGPDGEFHA | 331 | Q96M94 | |
| GPTTGEGALDLSDVH | 141 | O95684 | |
| EGLPLSAGKELVTGH | 181 | A2VCK2 | |
| PLGECIIAGHESGEL | 156 | Q13347 | |
| ETEDGHSVDPGLAGL | 221 | Q7Z5Y6 | |
| EGTIDGLEPGLHGLH | 116 | O14618 | |
| STDRVLGAHILGPGA | 446 | P09622 | |
| FGTGLTPLHLSDDGE | 406 | P98153 | |
| GPEEEDAGGLHVLLT | 911 | P14616 | |
| DAGGLHVLLTATPVG | 916 | P14616 | |
| HLIGHEGPGSLLSEL | 336 | P14735 | |
| GDRLLSVDGIPLHGA | 196 | Q9C0E4 | |
| GLRPDGIVGHSLGEV | 571 | P49327 | |
| ETEDGHSVDPGLAGL | 221 | P34820 | |
| HQGPGLLLGATDEDL | 496 | P55291 | |
| EDPALRHILDGGSGV | 756 | Q6P995 | |
| APGTAGTLHLVDLAG | 616 | Q96AC6 | |
| VHLEEAGILRAGPGG | 811 | Q9UN75 | |
| LHGLVADSNLTLGPG | 76 | P51460 | |
| VGTIGGTHIPLLAED | 396 | O15403 | |
| GREDTGLLATTHGPE | 1116 | Q96Q06 | |
| GIGLEGEHILDLHSP | 256 | O15034 | |
| EVELLGEHLPVGGFT | 311 | Q9H0F5 | |
| SGDEGEELGLPLLST | 491 | Q9BUR4 | |
| HLKTSGLAGEPEGEL | 861 | Q5JRA6 | |
| ADHSKSPEGLLGVLG | 426 | O75448 | |
| LSVEDALGLGEPEGS | 66 | Q6P5W5 | |
| PGSAGGVLAALLDHV | 176 | Q6P5W5 | |
| LLLEHQGSGPLECDG | 1151 | Q9P2F8 | |
| GLDLEAVRGGASHLP | 191 | O15357 | |
| PVDLSLGTLGEISGH | 291 | Q92561 | |
| LSLHIEPEEGSLAGG | 21 | P08F94 | |
| GEISRGPDVHLTHGL | 3011 | Q9P2P6 | |
| SVLFLHPDLGVGGAE | 16 | Q9H553 | |
| HPDLGVGGAERLVLD | 21 | Q9H553 | |
| GADLEHESEGGRTPL | 591 | Q8IWZ3 | |
| GTLGGDFLSSLPLHE | 501 | Q9Y6X2 | |
| LILHSGNILDSGPGD | 431 | O00562 | |
| LGDIQEPGHAEGILG | 16 | Q9BQY6 | |
| AETELVVPGHAEGLG | 811 | Q9BYN7 | |
| LLEGGPFSGLGEVIH | 716 | Q9P217 | |
| DGDSFLVLLEVPHGG | 71 | Q2QGD7 | |
| GGGHPLDLLSVTLAS | 311 | Q9NRA0 | |
| SLKHGPEVGLGDLSE | 4291 | Q15413 | |
| GRLLDVLSGHEGPIS | 491 | Q15269 | |
| EEVVGHTQGPLDGSL | 351 | Q9HBL0 | |
| GSHIGGRLLPEATTE | 656 | Q9UQD0 | |
| AGGGVEPSLEHLLDI | 126 | Q71RG4 | |
| LGHILGREPTSSEQG | 56 | Q04323 | |
| GDGVGEHPTQALLDI | 2046 | P27708 | |
| LPGGLEGSSAVAHLL | 3186 | Q96JG9 | |
| SEDGSEDGLPEGIHL | 441 | O75362 | |
| PEVRLLHAGSGADTG | 41 | A3KMH1 | |
| GHSTNLPDLVSGLGD | 436 | Q9H347 | |
| HPLELVVRDSLGGGS | 201 | Q8NAP8 | |
| HEEGDGATDGPARLL | 5036 | O14686 | |
| GPTEEIRALHAAIGG | 291 | O96009 | |
| EHRGALTLDPGAGEA | 216 | O15399 |